Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

886167

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Caesarean Sections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential benefits of vaginal seeding for children born by caesarean section.
tabling member constituency	Preston
tabling member printed	Sir Mark Hendrick
uin	136362
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>At this time, the Department has made no assessment of the potential benefits of vaginal seeding for children born by caesarean section.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 23/04/2018 13:44:00 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	473 label Biography information for Sir Mark Hendrick

886239

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Spinal Injuries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has conducted an impact assessment of the effect on people with spinal cord injuries resulting from the planned NHS Continuing Healthcare budget savings of £855 million by 2020-21.
tabling member constituency	Westmorland and Lonsdale
tabling member printed	Tim Farron
uin	136434
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England’s NHS Continuing Healthcare Strategic Improvement Programme aims to provide fair access to NHS Continuing Healthcare in a way which ensures better outcomes, better experience, and better use of resources.</p><p> </p><p>The programme does not aim to reduce spending on NHS Continuing Healthcare, but to reduce the rate of growth of expenditure. The projection is for spending on NHS Continuing Healthcare to increase by over 20% by 2020/21, or an average of approximately 3.9% per year.</p><p> </p><p>It is the responsibility of clinical commissioning groups to commission NHS Continuing Healthcare packages of care appropriate to the needs of individuals, and for assessing the impact of their funding decisions. Eligibility for NHS Continuing Healthcare is based on needs and is not specific to any particular condition or diagnosis.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 23/04/2018 12:23:04 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1591 label Biography information for Tim Farron

886240

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to promote timely and accurate diagnosis of inflammatory bowel disease.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136435
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136439 136442 136444 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

886241

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the Electronic Prescription Service to be made available in dispensing GP practices.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	136436
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>In December 2017, NHS Digital gave full roll out approval and assurance of a solution developed by EMIS Health to allow dispensing general practitioner (GP) practices to use the Electronic Prescription Service within their practice dispensary.</p><p> </p><p>EMIS Health supplies the EMIS Web prescribing system to approximately 50% of dispensing GP practices and will look to implement the Proscript Connect dispensing system at these sites in the first instance. This is expected to commence during summer 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:17:22 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

886242

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that rural GP practices have access to high-speed broadband to support their full participation in the Electronic Prescription Service.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	136437
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>The Department of Health and Social Care does not have responsibility for the rollout of access to high speed broadband. The Department for Digital, Culture, Media and Sport leads on the introduction of a broadband Universal Service Obligation.</p><p> </p><p>The Department of Health and Social Care is, through NHS Digital, ensuring general practitioner (GP) practices are able to access the best available broadband services through the Health and Social Care Network programme.</p><p> </p><p>The ability of GP practices to use the Electronic Prescription Service (EPS) is important to fully realise the benefits of the system to provide a more efficient and cost effective service. EPS is currently deployed to over 92% of GP practices.</p><p> </p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:20:04 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

886243

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Rural Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is assessing the potential merits of allowing dispensing doctors to sell over-the-counter medicines in rural areas.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	136438
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>The Department is not assessing the potential merits of allowing dispensing doctors to sell over-the-counter medicines in rural areas</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:16:06 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

886244

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to increase (a) access to and (b) use of faecal calprotectin in primary care in cases where inflammatory bowel disease is suspected.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136439
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136435 136442 136444 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

886247

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps (a) his Department and (b) NHS England are taking to improve the training for healthcare professionals in primary care to (i) diagnose and (ii) manage inflammatory bowel disease.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136442
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136435 136439 136444 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

886248

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nutrition: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of implementing Public Health England’s recommendation on achieving a 20 per cent reduction in children’s calorie intake by 2024.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	136443
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>A 20% reduction in calories from everyday foods that contribute to intakes, if achieved over five years, would prevent 35,370 premature deaths, save the National Health Service £4.5 billion in healthcare costs and save social care costs of around £4.48 billion, over a 25 year period.</p><p>This information is set out in Public Health England’s recent report “Calorie reduction: The scope and ambition for action” which is available at:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/685359/Calorie_reduction_The_scope_and_ambition_for_action.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/685359/Calorie_reduction_The_scope_and_ambition_for_action.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:10:46 answering member 4067 label Biography information for Steve Brine
tabling member	1491 label Biography information for Kerry McCarthy

886249

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NICE Quality Standard on inflammatory bowel disease, what steps he is taking to ensure that patients with suspected inflammatory bowel disease receive a specialist assessment within four weeks of referral.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136444
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136435 136439 136442 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn